Dr. Garlick is known especially for developing stem cells for tissue engineering, specifically for advanced treatments for oral health, cancer, scleroderma and complications of diabetes. He established the Center for Integrated Tissue Engineering at Tufts to accelerate the discovery and clinical application of new drugs using 3D tissues. Dr. Garlick has been equally committed to communicating science to the public. This discussion covers his pioneering stem cell research and how that led to his leadership in science communication.
Jonathan Garlick is Professor at Tufts University School of Dental Medicine, School of Medicine, and School of Engineering. His NIH-funded research laboratory has pioneered the use of stem cells for tissue engineering to develop new treatments for oral health, cancer, scleroderma and complications of diabetes. He is the Director of Science Communications for Tufts Clinical Translational Sciences Institute. He also directs a national science education and civic engagement initiative known as Civic Science (Tufts Initiative in Civic Science), which works to inform inclusive public learning about science that is designed to promote public dialogue about divisive science issues to strengthen civic life. Dr. Garlick has received many awards for both his research and his commitment to communicating science.
